About Incyte Corporation (INCY)
Incyte Corporation is a Biotechnology company operating in the Healthcare sector.
INCY trades on the US stock exchanges (NYSE/NASDAQ) and is classified as a large-cap stock .
Key Statistics
- Current Price
- $90.45
- Market Cap
- $18.00B
- 52-Week High
- $112.29
- 52-Week Low
- $53.56
- Sector
- Healthcare
- Industry
- Biotechnology
$1,000 Invested in Incyte Corporation (INCY)
How much would $1,000 invested in INCY be worth today?
What would $1,000 invested in INCY 1 year ago be worth today?
A $1,000 investment in Incyte Corporation (INCY) in 2025 would be worth $1,461 as of May 2026, representing a +46.1% total return.
What would $1,000 invested in INCY 3 years ago be worth today?
A $1,000 investment in Incyte Corporation (INCY) in 2023 would be worth $1,229 as of May 2026, representing a +22.9% total return.
What would $1,000 invested in INCY 5 years ago be worth today?
A $1,000 investment in Incyte Corporation (INCY) in 2021 would be worth $1,128 as of May 2026, representing a +12.8% total return.
What would $1,000 invested in INCY 10 years ago be worth today?
A $1,000 investment in Incyte Corporation (INCY) in 2016 would be worth $1,378 as of May 2026, representing a +37.8% total return.
What would $1,000 invested in INCY at IPO be worth today?
A $1,000 investment in Incyte Corporation (INCY) at IPO would be worth $48,240 as of May 2026, representing a +4724.0% total return.
Monthly Returns Heatmap
Over the past 32+ years (388 months), Incyte Corporation (INCY) has averaged a monthly return of +2.60% with a median return of +0.65%. The stock had 201 positive months (52%) and 182 negative months (47%). The best month in INCY's history was February 2000 with a +151.1% return, while the worst was March 2000 at -68.3%. Historically, December tends to be the strongest month (averaging +9.1%), and March the weakest (-4.1%).
INCY's longest winning streak was 8 consecutive months of gains, while its longest losing streak was 8 consecutive months of losses. The best full year was 2000 with a cumulative return of +134.2%, and the worst was 2002 at -124.1%.
Annual Returns
Over 33 years of trading history, Incyte Corporation (INCY) has delivered an average annual return of +25.47% with a median return of +10.00%. The compound annual growth rate (CAGR) is +11.84%. The stock posted gains in 19 years (58%) and losses in 14 years (42%).
INCY's best year was 2013 with a +204.82% gain, while the worst was 2002 at -76.54%. The longest streak of consecutive positive years was 4, and the longest losing streak was 3 years. INCY achieved double-digit gains (10%+) in 17 years. It suffered double-digit losses in 9 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -8.42% | $98.77 | $90.45 |
| 2025 | +43.00% | $69.07 | $98.77 |
| 2024 | +10.00% | $62.79 | $69.07 |
| 2023 | -21.83% | $80.32 | $62.79 |
| 2022 | +9.43% | $73.40 | $80.32 |
| 2021 | -15.61% | $86.98 | $73.40 |
| 2020 | -0.39% | $87.32 | $86.98 |
| 2019 | +37.32% | $63.59 | $87.32 |
| 2018 | -32.86% | $94.71 | $63.59 |
| 2017 | -5.55% | $100.27 | $94.71 |
| 2016 | -7.54% | $108.45 | $100.27 |
| 2015 | +48.34% | $73.11 | $108.45 |
| 2014 | +44.40% | $50.63 | $73.11 |
| 2013 | +204.82% | $16.61 | $50.63 |
| 2012 | +10.66% | $15.01 | $16.61 |
| 2011 | -9.36% | $16.56 | $15.01 |
| 2010 | +81.78% | $9.11 | $16.56 |
| 2009 | +140.37% | $3.79 | $9.11 |
| 2008 | -62.29% | $10.05 | $3.79 |
| 2007 | +72.09% | $5.84 | $10.05 |
| 2006 | +9.36% | $5.34 | $5.84 |
| 2005 | -46.55% | $9.99 | $5.34 |
| 2004 | +46.05% | $6.84 | $9.99 |
| 2003 | +50.00% | $4.56 | $6.84 |
| 2002 | -76.54% | $19.44 | $4.56 |
| 2001 | -21.85% | $24.88 | $19.44 |
| 2000 | -17.08% | $30.00 | $24.88 |
| 1999 | +60.54% | $18.69 | $30.00 |
| 1998 | -16.94% | $22.50 | $18.69 |
| 1997 | +74.76% | $12.88 | $22.50 |
| 1996 | +106.00% | $6.25 | $12.88 |
| 1995 | +80.18% | $3.47 | $6.25 |
| 1994 | +54.17% | $2.25 | $3.47 |
Frequently Asked Questions: INCY
What sector is INCY in? ▼
INCY operates in the Healthcare sector, specifically in the Biotechnology industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has INCY performed historically? ▼
Over 33 years of trading history, INCY has posted gains in 19 years (58% of the time). The best year was 2013 with a +204.8% return. Past performance does not guarantee future results.
How can I invest in INCY? ▼
You can invest in INCY through any brokerage account that offers access to US stock exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold INCY.
Last updated: 3/24/2026